Medacta Group SA Asset Resilience Ratio
Medacta Group SA asset resilience ratio. Medacta Group SA (MOVE) has an Asset Resilience Ratio of 0.86% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Medacta Group SA (MOVE) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Medacta Group SA (2016–2024)
Asset resilience ratio of Medacta Group SA from 2016 to 2024. This chart shows how Medacta Group SA's Asset Resilience Ratio has changed over time. See MOVE free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Medacta Group SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Medacta Group SA asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 0% |
| Short-term Investments | CHF7.45 Million | 0.86% |
| Total Liquid Assets | CHF7.45 Million | 0.86% |
Asset Resilience Insights
- Limited Liquidity: Medacta Group SA maintains only 0.86% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medacta Group SA Industry Peers by Asset Resilience Ratio
Compare Medacta Group SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Medacta Group SA Asset Resilience Ratio by Year (2016–2024)
Medacta Group SA asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Medacta Group SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.59% | CHF4.69 Million ≈ $5.93 Million |
CHF792.18 Million ≈ $1.00 Billion |
-0.42pp |
| 2023-12-31 | 1.01% | CHF7.05 Million ≈ $8.91 Million |
CHF695.87 Million ≈ $879.77 Million |
+0.88pp |
| 2022-12-31 | 0.14% | CHF802.00K ≈ $1.01 Million |
CHF584.49 Million ≈ $738.95 Million |
-- |
| 2021-12-31 | 0.00% | CHF0.00 ≈ $0.00 |
CHF489.27 Million ≈ $618.56 Million |
-- |
| 2020-12-31 | 0.29% | CHF1.30 Million ≈ $1.64 Million |
CHF441.94 Million ≈ $558.73 Million |
+0.23pp |
| 2019-12-31 | 0.06% | CHF259.00K ≈ $327.45K |
CHF412.56 Million ≈ $521.59 Million |
0.00pp |
| 2018-12-31 | 0.07% | CHF240.00K ≈ $303.42K |
CHF365.60 Million ≈ $462.21 Million |
-- |
| 2017-12-31 | 0.00% | CHF0.00 ≈ $0.00 |
CHF299.81 Million ≈ $379.04 Million |
-- |
| 2016-12-31 | 0.19% | CHF500.00K ≈ $632.14K |
CHF269.68 Million ≈ $340.95 Million |
-- |
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.